wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33828797-ADE4614C-897D-4BEB-A1A4-B14785E6D400
Q33828797-ADE4614C-897D-4BEB-A1A4-B14785E6D400
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33828797-ADE4614C-897D-4BEB-A1A4-B14785E6D400
Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA
P2860
Q33828797-ADE4614C-897D-4BEB-A1A4-B14785E6D400
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33828797-ADE4614C-897D-4BEB-A1A4-B14785E6D400
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d958b58fc0293c8f8d0c8d4c0e9578cb9e0dc15
P2860
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.